What price did Thomas E. Chorman receive per share in his latest SXI stock sale?

The reported sale of Standex (SXI) shares was executed at $305.56 per share for 50 shares of Common Stock. The transaction is characterized as a sale in an open-market or private transaction, with the price disclosed on a per-share basis.

Director Thomas Chorman sells 50 Standex (SXI) shares in 10b5-1 trade

Q: What insider transaction did Standex (SXI) director Thomas E. Chorman report?

Thomas E. Chorman reported selling 50 shares of Standex common stock on August 3, 2026 at $305.56 per share . The sale was described as an open-market or private transaction and executed under a pre-arranged Rule 10b5-1 trading plan dated November 6, 2025.

Q: Was the recent SXI insider sale by Thomas E. Chorman made under a Rule 10b5-1 plan?

Yes. The reported sale of 50 shares of Standex Common Stock was executed pursuant to an existing Rule 10b5-1 trading plan dated November 6, 2025. Such plans pre-arrange trades, reducing the significance of trade timing for interpreting insider sentiment.

Q: Does the latest SXI insider report from Thomas E. Chorman show any derivative or option activity?

The report lists a single transaction : a sale of 50 shares of Standex Common Stock. It does not report any derivative or option exercises in this instance, focusing solely on the common stock sale and the resulting direct share holdings.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Standex International director Thomas E. Chorman sold 50 shares of Common Stock on August 3, 2026 at $305.56 per share in an open-market or private transaction. Following the sale, he directly holds 12,366 shares. The trade was executed under a Rule 10b5-1 trading plan dated November 6, 2025.

Insider Trade Summary 10b5-1

Net Seller: 50 shares

Net Sell 1 txn

Insider CHORMAN THOMAS E

Role Director

Sold 50 shs ($15K)

Type	Security	Shares	Price	Value
Sale	Common Stock ^F1	50	$305.56	$15K

Holdings After Transaction: Common Stock — 12,366 shares (Direct)

Footnotes (1)

F1. Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

Key Figures

Shares sold: 50 shares Sale price per share: $305.56 Shares held after sale: 12,366 shares +1 more

4 metrics

Shares sold 50 shares Common Stock sale on August 3, 2026

Sale price per share $305.56 Price per share for the 50-share sale on August 3, 2026

Shares held after sale 12,366 shares Direct Common Stock holdings following the reported transaction

Net shares sold 50 shares Net share change across all transactions reported in this insider report

Key Terms

Rule 10b5-1 trading plan, open market or private transaction, Common Stock

3 terms

Rule 10b5-1 trading plan regulatory

"Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open market or private transaction regulatory

"Transaction described as a sale in open market or private transaction"

Common Stock financial

"Security title listed as Common Stock for this insider transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/04/2026 - 01:02 PM Accepted by SEC EDGAR 08/04/2026 - 01:02 PM

FAQ

What insider transaction did Standex (SXI) director Thomas E. Chorman report?

Thomas E. Chorman reported selling 50 shares of Standex common stock on August 3, 2026 at $305.56 per share. The sale was described as an open-market or private transaction and executed under a pre-arranged Rule 10b5-1 trading plan dated November 6, 2025.

How many Standex (SXI) shares does Thomas E. Chorman hold after this reported sale?

After the reported transaction, Thomas E. Chorman directly holds 12,366 shares of Standex International Common Stock. This post-transaction balance reflects a reduction of 50 shares from his prior position and represents only his reported direct ownership in this insider report.

Was the recent SXI insider sale by Thomas E. Chorman made under a Rule 10b5-1 plan?

Yes. The reported sale of 50 shares of Standex Common Stock was executed pursuant to an existing Rule 10b5-1 trading plan dated November 6, 2025. Such plans pre-arrange trades, reducing the significance of trade timing for interpreting insider sentiment.

Does the latest SXI insider report from Thomas E. Chorman show any derivative or option activity?

The report lists a single transaction: a sale of 50 shares of Standex Common Stock. It does not report any derivative or option exercises in this instance, focusing solely on the common stock sale and the resulting direct share holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHORMAN THOMAS E

(Last)

(First)

(Middle)

STANDEX INTERNATIONAL CORPORATION

23 KEEWAYDIN DRIVE, SUITE 300

(Street)

SALEM

NEW HAMPSHIRE

03079

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
STANDEX INTERNATIONAL CORP/DE/ [ SXI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/03/2026		S⁽¹⁾		50	D	$305.56	12,366	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

	/s/ Alan J. Glass	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR